Atlas FDA

RITHRON-XR CORONARY STENT SYSTEM

FDA premarket approval P030037 · decided 2005-04-29

Approval details

PMA number
P030037
Trade name
RITHRON-XR CORONARY STENT SYSTEM
Generic name
STENT, CORONARY
Applicant
Biotronik GmbH & Co. KG
Date received
2003-09-02
Decision date
2005-04-29
Days to decision
605 days
Decision code
APWD
Product code
MAF
Advisory committee
Cardiovascular
Expedited review
No
Location
Berlin
Statement
APPROVAL FOR THE RITHRON-XR CORONARY STENT SYSTEM. THE DEVICE IS INDICATED FOR USE IN PATIENTS ELIGIBLE FOR BALLOON ANGIOPLASTY WITH SYMPTOMATIC ISCHEMIC HEART DISEASE CHARACTERIZED BY DISCRETE DE NOVO CORONARY ARTERY LESIONS WITH REFERENCE VESSEL DIAMETER FROM >=3.0 MM OR <=4.0 MM AND TARGET LESION LENGTH <=20.0 MM.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.